Private Equity

With a new SVP of Growth, John Henry, RestorixHealth signals an aggressive push in the booming wound care market, navigating tech shifts and regulatory hurdles.

A strategic investment in cybersecurity firm ShorePoint reveals how private capital is becoming a critical force multiplier in securing federal agencies.

Pet Supplies Plus & Wag N' Wash break free with innovative financing. Here’s how autonomy and smart capital will reshape the competitive pet care market.

A key regulatory filing reveals First Trust Advisors' major stake in NCC Group, fueling speculation as the UK cybersecurity firm weighs a potential sale.

A new flooring finish promises unprecedented durability and safety, transforming high-traffic commercial spaces from clinics to retail boutiques.

Beyond fiber and 5G lies the infrastructure of resilience. A deep dive into how one company's rapid expansion is building a national network for urban recovery.

For the fifth year, GCM Grosvenor is a top workplace. We explore how their people-first strategy is a key asset in the competitive world of finance.

After key legal setbacks, Pason Systems settles its IP litigation. We decode what this confidential agreement means for investors and future innovation.

As the aging U.S. grid strains under explosive demand, industrial leaders are turning to microgrids for energy independence and financial stability.

A junior miner's savvy strategy to re-examine old drill core could unlock new value, positioning its gold-lithium project at the nexus of today's markets.

A key regulatory step for Hadron Energy's micro-reactor, backed by a unique SPAC model, signals a high-stakes bet on the future of U.S. energy.

After crossing $1B in assets, a community bank adds a healthcare PE expert to its board. This is more than a hire—it's a new strategy for growth.

In a stunning strategic shift, Transcontinental sells its largest division to ProAmpac, rewarding shareholders and refocusing on its printing roots.

Vyome's positive Phase 2 data targets a silent suffering in cancer care. This analysis explores its strategy to dominate a potential $1 billion market.

A deepening corporate governance battle pits STAAR Surgical's board against its largest shareholder and all major proxy firms over a $1.5B Alcon deal.

A top care provider changes hands not by choice, but by debt. What does Colisée's fate reveal about the risks of private equity in social care?

Amid a CEO change, Sherritt International faces a pivotal moment. Can a new leader steer its vital nickel and cobalt assets through volatile markets?

Antero Resources executes a complex asset swap, doubling down on the Marcellus Shale. We break down the financial engineering behind the multi-billion dollar deal.

New data reveals Syndax's Revuforj is a game-changer for leukemia, sparking a battle for market dominance in targeted cancer therapy.

A new dermatology clinic opens in rural Vermont, a case study in corporate-backed expansion. But does this new model solve the access crisis for all?